ERGi-USU-6 mesylate (Compound 7b) is an inhibitor of ERG and RIOK2 (IC50 values: 0.17 and 0.13 µM in VCaP cells, respectively). ERGi-USU-6 mesylate exhibits anticancer activity against ERG-positive prostate cancer[1].
Molecular Weight:
338.38
Purity:
95
CAS Number:
[2756327-67-8]
Formula:
C14H18N4O4S
Target:
Ser/Thr Kinase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted